Indications for hepatitis B immunoglobulin for neonates of HBsAg carrier mothers.
نویسندگان
چکیده
منابع مشابه
Indications for hepatitis B immunoglobulin for neonates of HBsAg carrier mothers.
In both these cases the nature of the foreign body in the palate defied diagnosis by either the parents or clinicians. Although this led to considerable delay in presentation, removal was simple and the palate left unscathed. The risks of dislodgement and aspiration of the plastic screwhead cap into the tracheobronchial tree, however, rendered this a potentially serious condition. Because screw...
متن کاملProtective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers
BACKGROUND Despite the use of hepatitis B (HB) vaccine and hepatitis B immunoglobulin (HBIG), a portion of infants are still non- or low-responders, or even immunoprophylaxis failure. We aimed to determine the immune response in the infants from the mothers being positive for hepatitis B surface antigen (HBsAg), by which the infants received three doses of HB vaccine in combination with two-dos...
متن کاملPrognosis of chronic hepatitis B transmitted from HBsAg positive mothers.
Nine children born to HBsAg positive mothers, who became chronic HBsAg carriers with associated liver disease, were followed for five to 10 years. Five children with active hepatitis or active cirrhosis at presentation achieved complete remission within six years, while three HBeAg positive patients with minimal histological lesions remained unchanged.
متن کاملImmuno-prophylaxis of babies borne to hepatitis B carrier mothers.
OBJECTIVES To examine the efficacy of current hepatitis B immuno-prophylaxis and estimate the prevalence of S-mutant infections among local newborn babies. DESIGN Prospective study. SETTING Regional hospital, Hong Kong. PATIENTS A total of 137 newborn babies delivered between the period of November 2000 and 30 June 2001 inclusive, whose mothers were chronic hepatitis B surface antigen car...
متن کاملCost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.
OBJECTIVE To compare the cost-effectiveness of hepatitis B virus (HBV) control strategies combining universal vaccination with hepatitis B immunoglobulin (HBIG) treatment for neonates of carrier mothers. METHODS Drawing on Taiwan's experience, we developed a decision-analytic model to estimate the clinical and economic outcomes for 4 strategies: (1) strategy V-universal vaccination; (2) strat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1984
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.289.6449.880